Literature DB >> 11585399

SPAMM, cine phase contrast imaging and fast spin-echo T2-weighted imaging in the study of intracranial cerebrospinal fluid (CSF) flow.

S E Connor1, R O'Gorman, P Summers, A Simmons, E M Moore, C Chandler, J M Jarosz.   

Abstract

AIM: To compare the qualitative assessment of cerebrospinal fluid (CSF) flow using a SPAMM (spatial modulation of magnetization) technique with cine phase contrast images (cine PC) and fast spin echo (FSE) T2-weighted images.
MATERIALS AND METHODS: SPAMM, PC and T2-weighted sequences were performed on 22 occasions in 19 patients. Eleven of the studies were performed following a neuroendoscopic third ventriculostomy (NTV), and in these cases, the success of the NTV was determined by clinical follow-up. Two observers used consensus to grade the presence of CSF flow at nine different sites for each study.
RESULTS: At 14 of the 178 matched sites, which could be assessed by both SPAMM and cine PC, SPAMM CSF flow grade was higher than that of cine PC. At a further 14/178 matched sites, the cine PC grade was higher than that of SPAMM. There was definite CSF flow at 113/182 (62%) of all the cine PC sites assessed, and 110/181 (61%) of all SPAMM sites assessed whilst 108/198 (54%) of FSE T2-weighted image sites demonstrated flow voids. Cine PC grades were higher than SPAMM at the cerebral aqueduct (P < 0.05, Wilcoxon sign rank test). Definite CSF flow within the anterior third ventricle was present in 4/5 (SPAMM) and 3/5 (cine PC) successful NTVs, 0/2 (SPAMM and cine PC) unsuccessful NTVs and 1/10 (SPAMM and cine PC) patients without NTV.
CONCLUSION: SPAMM provides a comparable assessment of intracranial CSF flow to that of cine phase contrast imaging at all CSF sites except the cerebral aqueduct. Copyright 2001 The Royal College of Radiologists.

Entities:  

Mesh:

Year:  2001        PMID: 11585399     DOI: 10.1053/crad.2001.0761

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  7 in total

1.  CSF flow imaging in the management of third ventriculostomy with a reversed fast imaging with steady-state precession sequence.

Authors:  Karl T Hoffmann; Thomas N Lehmann; Clemens Baumann; Roland Felix
Journal:  Eur Radiol       Date:  2002-12-13       Impact factor: 5.315

Review 2.  Cerebrospinal fluid flow imaging by using phase-contrast MR technique.

Authors:  B Battal; M Kocaoglu; N Bulakbasi; G Husmen; H Tuba Sanal; C Tayfun
Journal:  Br J Radiol       Date:  2011-05-17       Impact factor: 3.039

Review 3.  Current and emerging MR imaging techniques for the diagnosis and management of CSF flow disorders: a review of phase-contrast and time-spatial labeling inversion pulse.

Authors:  S Yamada; K Tsuchiya; W G Bradley; M Law; M L Winkler; M T Borzage; M Miyazaki; E J Kelly; J G McComb
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-10       Impact factor: 3.825

4.  Analysis of endoscopic third ventriculostomy patency by MRI: value of different pulse sequences, the sequence parameters, and the imaging planes for investigation of flow void.

Authors:  Alp Dinçer; Erdem Yildiz; Saeed Kohan; M Memet Özek
Journal:  Childs Nerv Syst       Date:  2010-07-15       Impact factor: 1.475

Review 5.  Endoscopic third ventriculostomy for obstructive hydrocephalus.

Authors:  Dieter Hellwig; Joachim Andreas Grotenhuis; Wuttipong Tirakotai; Thomas Riegel; Dirk Michael Schulte; Bernhard Ludwig Bauer; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2004-11-27       Impact factor: 3.042

Review 6.  MR assessment of pediatric hydrocephalus: a road map.

Authors:  Charles Raybaud
Journal:  Childs Nerv Syst       Date:  2015-09-04       Impact factor: 1.475

7.  Evaluation of aqueductal patency in patients with hydrocephalus: three-dimensional high-sampling-efficiency technique (SPACE) versus two-dimensional turbo spin echo at 3 Tesla.

Authors:  Murat Ucar; Melike Guryildirim; Nil Tokgoz; Koray Kilic; Alp Borcek; Yusuf Oner; Koray Akkan; Turgut Tali
Journal:  Korean J Radiol       Date:  2014-11-07       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.